24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

872

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK573719/GW642444 125/25

125/25 mcg once-daily

DRUG

GSK573719/GW642444 62.5/25

62.5/25 mcg once-daily

DRUG

GSK573719

125 mcg once-daily

DRUG

tiotropium bromide

18 mcg once-daily

Trial Locations (100)

1459

GSK Investigational Site, Boksburg North

2139

GSK Investigational Site, Concord

3050

GSK Investigational Site, Parkville

3199

GSK Investigational Site, Frankston

4021

GSK Investigational Site, Kippa-Ring

4091

GSK Investigational Site, Durban

4152

GSK Investigational Site, Carina Heights

4870

GSK Investigational Site, Cairns

5000

GSK Investigational Site, Adelaide

5041

GSK Investigational Site, Daw Park

6009

GSK Investigational Site, Nedlands

7764

GSK Investigational Site, Gatesville

9301

GSK Investigational Site, Bloemfontein

10629

GSK Investigational Site, Berlin

12099

GSK Investigational Site, Berlin

14000

GSK Investigational Site, México

15009

GSK Investigational Site, Beaver

15562

GSK Investigational Site, Rüdersdorf

16303

GSK Investigational Site, Schwedt

16515

GSK Investigational Site, Oranienburg

22335

GSK Investigational Site, Hamburg

26505

GSK Investigational Site, Morgantown

27909

GSK Investigational Site, Elizabeth City

28207

GSK Investigational Site, Charlotte

29303

GSK Investigational Site, Spartanburg

29640

GSK Investigational Site, Easley

30046

GSK Investigational Site, Lawrenceville

32174

GSK Investigational Site, Ormond Beach

33765

GSK Investigational Site, Clearwater

34080

GSK Investigational Site, Durango

34121

GSK Investigational Site, Kassel

35501

GSK Investigational Site, Jasper

36608

GSK Investigational Site, Mobile

38300

GSK Investigational Site, Wolfenbüttel

42431

GSK Investigational Site, Madisonville

45040

GSK Investigational Site, Zapopan

45231

GSK Investigational Site, Cincinnati

45355

GSK Investigational Site, Essen

45359

GSK Investigational Site, Essen

52349

GSK Investigational Site, Düren

55116

GSK Investigational Site, Mainz

56068

GSK Investigational Site, Koblenz

60389

GSK Investigational Site, Frankfurt am Main

63141

GSK Investigational Site, St Louis

63739

GSK Investigational Site, Aschaffenburg

64020

GSK Investigational Site, Monterrey

66606

GSK Investigational Site, Topeka

68723

GSK Investigational Site, Schwetzingen

70115

GSK Investigational Site, New Orleans

70503

GSK Investigational Site, Lafayette

90048

GSK Investigational Site, Los Angeles

92647

GSK Investigational Site, Huntington Beach

97504

GSK Investigational Site, Medford

100379

GSK Investigational Site, Ploieşti

130086

GSK Investigational Site, Târgovişte

900002

GSK Investigational Site, Constanța

3460001

GSK Investigational Site, Talca

5480000

GSK Investigational Site, Port Montt

7500551

GSK Investigational Site, Santiago

7500710

GSK Investigational Site, Santiago

7500800

GSK Investigational Site, Santiago

7601003

GSK Investigational Site, Santiago

8380453

GSK Investigational Site, Santiago

C1424BSF

GSK Investigational Site, Buenos Aires

C1028AAP

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

M5500CCG

GSK Investigational Site, Mendoza

C1425BEN

GSK Investigational Site, Buenos Aires

C1426ABP

GSK Investigational Site, Buenos Aires

R2H 2A6

GSK Investigational Site, Winnipeg

R2K 3S8

GSK Investigational Site, Winnipeg

A0A 1G0

GSK Investigational Site, Bay Roberts

B2N 1L2

GSK Investigational Site, Truro

P3E 1H5

GSK Investigational Site, Greater Sudbury

L5M 2V8

GSK Investigational Site, Mississauga

M5T 3A9

GSK Investigational Site, Toronto

J8Y 6S8

GSK Investigational Site, Gatineau

G1V 4G5

GSK Investigational Site, Québec

G6W 5M6

GSK Investigational Site, St-Romulad

04207

GSK Investigational Site, Leipzig

0041

GSK Investigational Site, Die Wilgers

0181

GSK Investigational Site, Groenkloof

0002

GSK Investigational Site, Pretoria

0380

GSK Investigational Site, Thabazimbi

420-767

GSK Investigational Site, Bucheon-si

361-711

GSK Investigational Site, Cheongju, Chungcheongbuk-do

705-717

GSK Investigational Site, Daegu

400-711

GSK Investigational Site, Incheon

405-760

GSK Investigational Site, Incheon

220-701

GSK Investigational Site, Kangwon-do

463-707

GSK Investigational Site, Seongnam-si, Gyeonggi-do

100-032

GSK Investigational Site, Seoul

110-744

GSK Investigational Site, Seoul

130-702

GSK Investigational Site, Seoul

130-848

GSK Investigational Site, Seoul

136-705

GSK Investigational Site, Seoul

143-729

GSK Investigational Site, Seoul

152-703

GSK Investigational Site, Seoul

156-707

GSK Investigational Site, Seoul

Unknown

GSK Investigational Site, Seoul

443-721

GSK Investigational Site, Suwon, Kyonggi-do

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01316913 - 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter